Mark O'DRiscoll

Mark O'DRiscoll

Auto-generated profile, based on publicly available information

Mark O'DRiscoll

Genome Damage and Stability Centre, University of Sussex, Brighton BN1 9RQ, UK

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2004 in Cancer Research
Verified
Journal Article
Closed access
PDF file
TSTom Stiff
Tom Stiff
MOMark O’dRiscoll
Mark O’dRiscoll
NRNicole Rief
Nicole Rief
KIKuniyoshi Iwabuchi
Kuniyoshi Iwabuchi
MLMarkus LöbRich
Markus LöbRich
PJPenny A. Jeggo
Penny A. Jeggo
H2AX phosphorylation is an early step in the response to DNA damage. It is widely accepted that ATM (ataxia telangiectasia mutated protein) phosphorylates H2AX in response to DNA double-strand breaks (DSBs). Whether DNA-dependent protein kinase (DNA-PK) plays any role in this response is unclear. Here, we show that H2AX phosphorylation after exposure to ionizing radiation (IR) occurs to similar extents in human fibroblasts and in mouse embryo fibroblasts lacking either DNA-PK or ATM but is ablated in ATM-deficient cells treated with LY294002, a drug that specifically inhibits DNA-PK. Additionally, we show that inactivation of both DNA-PK and ATM is required to ablate IR-induced H2AX phosphorylation in chicken cells. We confirm that H2AX phosphorylation induced by DSBs in nonreplicating cells is ATR (ataxia telangiectasia and Rad3-related protein) independent. Taken together, we conclude that under most normal growth conditions, IR-induced H2AX phosphorylation can be carried out by ATM and DNA-PK in a redundant, overlapping manner. In contrast, DNA-PK cannot phosphorylate other proteins involved in the checkpoint response, including chromatin-associated Rad17. However, by phosphorylating H2AX, DNA-PK can contribute to the presence of the damage response proteins MDC1 and 53BP1 at the site of the DSB.

24 June 2012 in Nature Genetics
Verified
Journal Article
Open access
PDF file
FCFinding of Rare Disease Genes (FORGE) Canada Consortium
Finding of Rare Disease Genes (FORGE) Canada Consortium
JRJean-Baptiste Rivière
Jean-Baptiste Rivière
GMGhayda M Mirzaa
Ghayda M Mirzaa
BOBrian J O'ROak
Brian J O'ROak
MBMargaret Beddaoui
Margaret Beddaoui
WDWilliam B Dobyns
William B Dobyns
William Dobyns and colleagues report de novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA in the sporadic overgrowth syndromes megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) and megalencephaly-capillary malformation (MCAP). Megalencephaly-capillary malformation (MCAP) and megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndromes are sporadic overgrowth disorders associated with markedly enlarged brain size and other recognizable features1,2,3,4,5. We performed exome sequencing in 3 families with MCAP or MPPH, and our initial observations were confirmed in exomes from 7 individuals with MCAP and 174 control individuals, as well as in 40 additional subjects with megalencephaly, using a combination of Sanger sequencing, restriction enzyme assays and targeted deep sequencing. We identified de novo germline or postzygotic mutations in three core components of the phosphatidylinositol 3-kinase (PI3K)-AKT pathway. These include 2 mutations in AKT3, 1 recurrent mutation in PIK3R2 in 11 unrelated families with MPPH and 15 mostly postzygotic mutations in PIK3CA in 23 individuals with MCAP and 1 with MPPH. Our data highlight the central role of PI3K-AKT signaling in vascular, limb and brain development and emphasize the power of massively parallel sequencing in a challenging context of phenotypic and genetic heterogeneity combined with postzygotic mosaicism.

1 January 2006 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
MOMark O'DRiscoll
Mark O'DRiscoll
PJPenny A. Jeggo
Penny A. Jeggo

1 December 2001 in Molecular Cell
Verified
Journal Article
Closed access
MOMark O'DRiscoll
Mark O'DRiscoll
KCKaren M. Cerosaletti
Karen M. Cerosaletti
PGPierre-M Girard
Pierre-M Girard
YDYan Dai
Yan Dai
MSMarkus Stumm
Markus Stumm
PCPatrick Concannon
Patrick Concannon

23 December 2007 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EGElen Griffith
Elen Griffith
SWSarah Walker
Sarah Walker
CMCarol-Anne Martin
Carol-Anne Martin
PVPaola Vagnarelli
Paola Vagnarelli
TSTom Stiff
Tom Stiff
MOMark O'DRiscoll
Mark O'DRiscoll

23 November 2006 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
TSThomas Stiff
Thomas Stiff
SWSarah A Walker
Sarah A Walker
KCKaren Cerosaletti
Karen Cerosaletti
AGAaron A Goodarzi
Aaron A Goodarzi
EPEva Petermann
Eva Petermann
PJPenny A Jeggo
Penny A Jeggo
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.